DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.

Biotechnology

Health Care

Therapeutics

DJS Antibodies

DJS Antibodies' headquarters in Oxford, United Kingdom

Dale Starkie

Joe Illingworth

Amanda Hall

Chris Lynch

Liz Allen

Amy Sawtell

Adam Kupinski

Cara Saunders

Tom Mills

Louise Speight

Megan Ingham

Lara Bavinton

Genevieve Labbe

Description

People (7)